Skip to main content
LMAT
NASDAQ Industrial Applications And Services

LeMaitre Vascular Reports Strong Q1 Results and Raises Full-Year Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$112
Mkt Cap
$2.551B
52W Low
$78.01
52W High
$118.01
52W Position info
44% above low
Off High info
5.1% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LMAT sits 44% above its 52-week low of $78.01.

Summary

LeMaitre Vascular reported exceptionally strong Q1 2026 financial results, with sales up 11% and EPS up 42%, leading the company to raise its full-year guidance for both sales and adjusted EPS.


Key Events · Earnings and Guidance · LMAT

  • Strong Q1 2026 Financial Performance

    LeMaitre Vascular reported Q1 2026 sales of $66.6 million, an 11% increase year-over-year, and diluted EPS of $0.68, a 42% increase, significantly exceeding prior year results due to higher ASPs, geographic expansion, and manufacturing efficiencies.

  • Raised Full-Year 2026 Guidance

    The company increased its full-year 2026 guidance, projecting midpoint sales of $280 million (+12% organic) and adjusted EPS of $3.00 (+26% adjusted), signaling strong confidence in continued growth and operational leverage.

  • Quarterly Dividend Declared

    The Board of Directors approved a quarterly dividend of $0.25 per share, consistent with the 25% increase announced earlier in the year, payable on June 4, 2026.


Analysis · LMAT · Industrial Applications And Services

LeMaitre Vascular's strong Q1 performance, marked by double-digit growth in sales and a significant 42% increase in EPS, demonstrates robust operational execution and market demand for its vascular devices. The decision to raise full-year guidance, particularly for sales and adjusted EPS, signals management's confidence in sustained momentum and operational leverage. This positive financial update, following a recent news report on the same day, reinforces a strong investment thesis and could lead to positive investor sentiment.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 44.9% of the 1407 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LMAT was trading at $112.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $78.01 to $118.01. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LMAT - Latest Insights

LMAT
Nov 05, 2026, 6:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $80.60
Real-time Price: $83.00 info
Change: +$2.40 (+3%) info
Market Cap: $1.909B info
LMAT
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $78.48
Real-time Price: $83.00 info
Change: +$4.52 (+6%) info
Market Cap: $1.909B info
LMAT
Nov 04, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $76.11
Real-time Price: $83.00 info
Change: +$6.89 (+9%) info
Market Cap: $1.909B info
LMAT
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $87.92
Real-time Price: $83.00 info
Change: -$4.92 (-6%) info
Market Cap: $1.909B info
LMAT
Oct 15, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $83.16
Real-time Price: $83.00 info
Change: -$0.160 (-0.19%) info
Market Cap: $1.909B info